NSCLC Stage IIIB, NSCLC Stage IIIC
1 clinical trials · Condition
◉ Watch NSCLC Stage IIIB, NSCLC Stage IIIC
| Record | Firm | Date |
|---|---|---|
| Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC (NCT06829641) | West China Hospital | 2025-08-09 |
Track NSCLC Stage IIIB, NSCLC Stage IIIC automatically
Every clearance here is in the API, with alerts when new ones post.